The global Stents market size was valued at USD 12.5 billion in 2023, driven by the technological advancements across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 20.4 billion by 2032.
Secondly, the shift towards personalized medicine has instigated the development of stents tailored to individual patient needs, optimizing treatment outcomes. Technological strides have also manifested in the form of drug-eluting stents (DES), which release medication slowly to prevent cell proliferation, thereby reducing re-narrowing chances. This innovation has gained traction due to its enhanced efficacy compared to bare-metal stents. Furthermore, there's a growing emphasis on minimally invasive procedures, driving demand for stents in percutaneous coronary interventions.
The market also witnesses geographical expansion, with Asia Pacific showing robust growth due to rising cardiovascular ailments and expanding healthcare infrastructure. However, the market grapples with challenges like stringent regulatory scrutiny and concerns over stent thrombosis. In essence, the stents market is in a state of flux, shaped by technological innovations, patient-centric approaches, and evolving healthcare landscapes.
The market also finds momentum in the increasing preference for minimally invasive surgeries and the broader acceptance of stenting procedures in emerging economies. While North America and Europe continue to be dominant players due to advanced healthcare infrastructure, the Asia-Pacific region is showcasing rapid growth owing to burgeoning healthcare needs and infrastructure development. Despite the promising landscape, the stents market grapples with challenges, including regulatory stringencies and potential post-surgical complications. Nevertheless, with continued technological innovation and research, the global stents market remains poised for sustained growth.
This product will be delivered within 5-7 business days.
Stents: Introduction
Stents are small and expandable tubes that are used to treat narrowed or weakened arteries in the body. Primarily designed to prevent blockages and restore blood flow, stents have become an essential device in cardiovascular treatments. The global stents market has evolved over the years, driven by increasing incidences of cardiovascular diseases, technological advancements, and an aging population.Key Trends in the Global Stents Market
The global stents market, critical in addressing vascular blockages, has observed several pivotal trends recently. Firstly, the advent of bioresorbable stents has garnered attention, offering benefits over traditional metallic stents by being naturally absorbed by the body after fulfilling their function. This evolution aims to mitigate long-term complications and further interventions.Secondly, the shift towards personalized medicine has instigated the development of stents tailored to individual patient needs, optimizing treatment outcomes. Technological strides have also manifested in the form of drug-eluting stents (DES), which release medication slowly to prevent cell proliferation, thereby reducing re-narrowing chances. This innovation has gained traction due to its enhanced efficacy compared to bare-metal stents. Furthermore, there's a growing emphasis on minimally invasive procedures, driving demand for stents in percutaneous coronary interventions.
The market also witnesses geographical expansion, with Asia Pacific showing robust growth due to rising cardiovascular ailments and expanding healthcare infrastructure. However, the market grapples with challenges like stringent regulatory scrutiny and concerns over stent thrombosis. In essence, the stents market is in a state of flux, shaped by technological innovations, patient-centric approaches, and evolving healthcare landscapes.
Global Stents Market Segmentation
Market Breakup by Product Type
- Coronary Stents
- Peripheral Stents
- Neurovascular Stents
- Stent-Related
Market Breakup by Type
- Self-Expandable Stents
- Balloon-Expandable Stents
Market Breakup by Material
- Metallic Stents
- Polymer Stents
- Bioresorbable Stents
- Others
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Stents Market Overview
The global stents market has cemented its position as a pivotal segment within the broader medical device industry, primarily catering to the escalating incidences of cardiovascular diseases worldwide. Primarily used as a therapeutic device for arterial blockages, the market's growth trajectory is powered by the rising geriatric population and the corresponding increase in cardiovascular conditions. A notable innovation within this sphere is the surge in the adoption of drug-eluting stents (DES), which offer enhanced efficacy in preventing arterial re-narrowing compared to their bare-metal counterparts. Moreover, bioresorbable stents, with their promise of reduced long-term complications, represent a significant advancement in stent technology.The market also finds momentum in the increasing preference for minimally invasive surgeries and the broader acceptance of stenting procedures in emerging economies. While North America and Europe continue to be dominant players due to advanced healthcare infrastructure, the Asia-Pacific region is showcasing rapid growth owing to burgeoning healthcare needs and infrastructure development. Despite the promising landscape, the stents market grapples with challenges, including regulatory stringencies and potential post-surgical complications. Nevertheless, with continued technological innovation and research, the global stents market remains poised for sustained growth.
Global Stents Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Boston Scientific Corporation
- BD
- Medtronic
- Abbott
- Cook Medical
- Merit Medical Systems
- Novatech SA
- Terumo Corporation
- MicroPort Scientific Corporation
- Fuji Systems Corp.
- MICRO-TECH EUROPE
- Vascular Concepts
- Olympus Corporation
- W. L. Gore & Associates Inc.
- B. Braun Melsungen AG
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface
3 Global Stents Market Overview
4 Global Stents Market Landscape
5 Global Stents Market Dynamics
6 Global Stents Market Segmentation
7 North America Stents Market
8 Europe Stents Market
9 Asia Pacific Stents Market
10 Latin America Stents Market
11 Middle East and Africa Stents Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Stents Market - Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- Boston Scientific Corporation
- BD
- Medtronic
- Abbott
- Cook Medical
- Merit Medical Systems
- Novatech SA
- Terumo Corporation
- MicroPort Scientific Corporation
- Fuji Systems Corp.
- MICRO-TECH EUROPE
- Vascular Concepts
- Olympus Corporation
- W. L. Gore & Associates Inc.
- B. Braun Melsungen AG
Methodology
LOADING...